News & Perspective

Apr 16, 2019

Apr 16, 2019

News Scan for Apr 16, 2019

Needle-free flu vaccine boost
Promise for chikungunya vaccine
Global flu mostly dropping

Oct 01, 2014

Oct 01, 2014

News Scan for Oct 01, 2014

Funds for new flu tests
Simvastatin for ARDS
Flawed FEMA system

Nov 09, 2012

Nov 09, 2012

BioCryst may drop quest for US approval of peramivir

(CIDRAP News) – BioCryst Pharmaceuticals Inc. signaled yesterday it will probably give up on seeking a US license for the influenza drug peramivir, a move that would reduce the already limited options for severely ill flu patients in need of an intravenous antiviral drug.

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»